Given that TAL1 is required for leukemic cell survival (10–12), we further test if −31CBSinv/inv affects T-ALL cell proliferation and leukemogenesis in vitro and in vivo as compared to the vector control and the −31CBS−/− clone. The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.